Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III)-Reference-Cited by-同舟云学术

Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III)

Published:2018-11-14 Issue:1 Volume:59 Page:217-225
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Karafin Matthew S.¹^ORCID,Tan Sylvia²,Tormey Christopher A.³⁴,Spencer Bryan R.³⁵,Hauser Ronald G.³⁴,Norris Philip J.⁶⁷^ORCID,Roubinian Nareg H.⁶⁷,Wu Yanyun³⁸,Triulzi Darrell J.⁹,Kleinman Steve¹⁰,Gottschall Jerome L.¹,Hendrickson Jeanne E.³¹¹^ORCID

Affiliation:

1. Blood Center of WisconsinMedical College of Wisconsin Milwaukee Wisconsin

2. RTI International Rockville Maryland

3. Department of Laboratory MedicineYale University New Haven Connecticut

4. VA CT West Haven Connecticut

5. American Red Cross Dedham Massachusetts

6. University of California San Francisco California

7. Blood Systems Research Institute San Francisco California

8. Bloodworks Northwest Seattle Washington

9. University of Pittsburgh and Institute of Transfusion Medicine Pittsburgh Pennsylvania

10. University of British Columbia Vancouver British Columbia Canada

11. Department of PediatricsYale University New Haven Connecticut

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15004

Reference30 articles.

1. Red Blood Cell Alloimmunization Mitigation Strategies

2. FDA. US Department of Health and Human Services. Fatalities reported to the FDA following blood collection; Available from:http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability accessed July 1 2018.

3. The persistence and evanescence of blood group alloantibodies in men

4. Management and prevention of red cell alloimmunization in pregnancy: a systematic review;Moise KJ;Obstet Gynecol,2012

5. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA;Transfusion;2024-01-30

2. Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion;Blood Advances;2023-12-26

3. Blood Donor Sex and Outcomes in Transfused Infants;Clinics in Perinatology;2023-12

4. The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease;La Presse Médicale;2023-12

5. Prevalence of red blood cell alloantibodies among blood donors in the French Military Blood Institute: A 10‐year retrospective study;Vox Sanguinis;2023-10-22